Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-23

Clinical Trial Update: To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

View source ↗

Summary

A completed real-world trial comparing TNF inhibitors, used as monotherapy or with methotrexate, to tofacitinib, used as monotherapy or with methotrexate, in rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)
  • Certolizumab pegol (certolizumab pegol)
  • Etanercept (etanercept)
  • Infliximab (infliximab)
  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2025-12-23